Research Topics
| J MenzinSummaryAffiliation: Boston Health Economics Country: USA Publications
| Collaborators
|
Detail Information
Publications
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitusJoseph Menzin
Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
J Manag Care Pharm 16:264-75. 2010..However, limited data from clinical practice are available regarding the relationship between glycemic control and medical costs associated with diabetes care...
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJoseph Menzin
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 0245 USA
J Manag Care Pharm 19:S24-40. 2013..Improvements in adherence have the potential to improve patient and payer burden in terms of improved clinical outcomes and lower nonpharmacy medical resource utilization. ..
The economic burden of advanced liver disease among patients with hepatitis C virus: a large state Medicaid perspectiveJoseph Menzin
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
BMC Health Serv Res 12:459. 2012..ALD can lead to significant clinical and economic consequences, including liver transplantation. This study evaluated the health care costs associated with ALD among HCV infected patients in a Medicaid population...
Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessationJoseph Menzin
Boston Health Economics, Inc, Waltham, MA 02451, USA
BMC Med Res Methodol 12:87. 2012..The estimation of indirect costs is commonly done on a country-specific basis. However, there are few studies that evaluate indirect costs across countries using a consistent methodology...
Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health recordsJ Menzin
Outcomes Research, Boston Health Economics, Inc, Waltham, MA 02451, USA
J Thromb Haemost 10:596-605. 2012..However, there are limited data on the association between INR correction and mortality...
Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health recordsJ Menzin
Joseph Menzin, PhD, Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Thromb Haemost 107:662-72. 2012..5), 39% of patients' INRs remained uncorrected. For a substantial proportion of patients, the INRs remain inadequately or uncorrected following FFP administration, with estimates varying depending on the INR threshold used...
Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysisKathleen Lang
Boston Health Economics, Inc, Waltham, MA, USA
BMC Health Serv Res 9:227. 2009..This retrospective cohort study evaluated healthcare resource use among US Medicare beneficiaries diagnosed with CRC between 1992 and 2002...
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysisKathleen Lang
Boston Health Economics, Inc, Waltham, USA
BMC Cancer 9:227. 2009..The purpose of this study was to estimate the relative impact of changes in demographics, stage at detection, treatment mix, and medical technology on 5-year survival among older colorectal cancer (CRC) patients...
Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid programJoseph Menzin
Boston Health Economics Inc, 20 Fox Road, Waltham, MA 02451, USA
Psychiatr Serv 54:719-23. 2003..Rates of medication adherence over a one-year period were assessed among outpatients with schizophrenia who initiated therapy with conventional or atypical antipsychotic agents...
One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims databaseJoseph Menzin
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Curr Med Res Opin 24:461-8. 2008..Acute coronary syndromes (ACS) are life-threatening disorders requiring intensive medical management or invasive cardiovascular procedures. Limited data exist on the costs and resource utilization associated with ACS...
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare populationJoseph Menzin
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Respir Med 102:1248-56. 2008..Although the economic burden of COPD has gained attention in recent years, data on the costs of COPD among U.S. Medicare beneficiaries are lacking...
Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?Joseph Menzin
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Expert Rev Pharmacoecon Outcomes Res 9:257-64. 2009..Nonetheless, the policy and social welfare implications of a short-term focus must be carefully evaluated, considering the established favorable long-term cost-effectiveness of smoking cessation...
A model of the economic impact of a bipolar disorder screening program in primary careJoseph Menzin
Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
J Clin Psychiatry 70:1230-6. 2009..This study models the cost effectiveness of screening for bipolar disorder among adults presenting for the first time with symptoms of major depressive disorder...
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureusJoseph Menzin
Boston Health Economics, Inc, Waltham, MA 02451, USA
Am J Infect Control 38:44-9. 2010..Staphylococcus aureus (SA) is a common bacterial pathogen in skin and skin structure infections (SSSIs). Limited data exist on hospital treatment patterns and costs for SA-SSSIs...
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patientsJoseph Menzin
Boston Health Economics, Inc, Waltham, MA 02451, USA
Am J Health Syst Pharm 66:1711-7. 2009..The mortality, length of hospitalization, and costs associated with invasive fungal infections (IFIs) in hospitalized patients were studied...
The economic costs to United States hospitals of invasive fungal infections in transplant patientsJoseph Menzin
Boston Health Economics, Waltham, MA 02451, USA
Am J Infect Control 39:e15-20. 2011..Data on the economic burden of IFIs in the United States are sparse...
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin
Boston Health Economics, Inc, Waltham, MA, USA
Pharmacoeconomics 29:839-61. 2011..In order to realize these cost savings, efforts will be required to promote and effectively implement changes in treatment practices...
The economics of squamous cell carcinoma of the head and neckJoseph Menzin
Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
Curr Opin Otolaryngol Head Neck Surg 15:68-73. 2007..SCCHN is a relatively deadly disease. Approximately 50% of patients survive to 5 years, and surgery and chemoradiotherapy can leave survivors with pain, disfigurement, and disability that further add to the burden of the disease...
Cost analysis of amlodipine versus enalapril in patients with coronary artery disease and normal blood pressure: findings from the CAMELOT economic substudyJoseph Menzin
Boston Health Economics, Inc, Waltham, Massachusetts, USA
Appl Health Econ Health Policy 6:157-62. 2008..To analyse 2-year hospitalization and cost data collected during a prospective, double-blind, randomized, controlled trial comparing amlodipine, enalapril and placebo in normotensive patients with coronary artery disease (CAD)...
Potential short-term economic benefits of improved glycemic control: a managed care perspectiveJ Menzin
Boston Health Economics, Billerica, Massachusetts 01821, USA
Diabetes Care 24:51-5. 2001..The goal of this study was to examine the potential impact of improved glycemic control on selected short-term complications of diabetes and associated costs in a managed care setting...
Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care studyJoseph Menzin
Boston Health Economics, 20 Fox Road, Waltham, MA 02451 1007, USA
Ann Pharmacother 39:446-51. 2005..Anticoagulation clinics are often used to administer warfarin therapy more effectively...
Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysisJoseph Menzin
Boston Health Economics, Inc, Waltham, Massachusetts, USA
Drugs Aging 21:737-46. 2004..To fill this void, our study uses population-based data to evaluate longer-term treatment patterns, outcomes and costs among elderly Medicare beneficiaries following their diagnosis of CML...
Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare dataJoseph Menzin
Boston Health Economics, Waltham, MA 02451, USA
Value Health 8:140-8. 2005....
Adherence to calcium channel blocker therapy in older adults: a comparison of amlodipine and felodipineJ Menzin
Boston Health Economics, Inc, Waltham, MA, USA
J Int Med Res 32:233-9. 2004..This study suggests that use of amlodipine may be associated with improved adherence, compared with felodipine, among older out-patients in the Medi-Cal program...
The outcomes and costs of acute myeloid leukemia among the elderlyJoseph Menzin
Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
Arch Intern Med 162:1597-603. 2002..The incidence of acute myeloid leukemia (AML) among the elderly can be expected to grow as the population continues to age. However, data on current treatment practices and costs for this form of cancer are sparse...
A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to FranceJ Menzin
Boston Health Economics, Inc, Billerica, Massachusetts, USA
Pharmacoeconomics 19:69-78. 2001..Although various prescription drugs may be equally effective in promoting sleep, some may lead to substantial impairment in psychomotor functioning and an increased risk of motor vehicle accidents...
Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillationLuke Boulanger
Boston Health Economics, Waltham, MA 02451, USA
Ann Pharmacother 40:1024-9. 2006..55). CONCLUSIONS: In this Medicaid population with NVAF, warfarin use was low and was associated with a relatively modest reduction in thromboembolic events, with no increase in major bleeding risk...
Trends in the treatment of acute myeloid leukaemia in the elderlyKathleen Lang
Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
Drugs Aging 22:943-55. 2005..Our findings can be used as a baseline against which the benefits of new therapies can be compared...
Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neckKathleen Lang
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Arch Otolaryngol Head Neck Surg 135:582-8. 2009..To evaluate the incidence and costs of complications due to radiotherapy alone vs platinum-based chemoradiotherapy among patients diagnosed as having advanced squamous cell carcinoma of the head and neck (ASCCHN) from a payer perspective...
Cost-effectiveness of migraine prevention: the case of topiramate in the UKJ S Brown
Harvard Medical School/Harvard Pilgrim Health Care, Department of Ambulatory Care and Prevention, Boston, MA, USA
Cephalalgia 26:1473-82. 2006..This analysis suggests that topiramate is a cost-effective treatment for migraine prevention compared with no preventive treatment...
Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practiceL Boulanger
Boston Health Economics, Waltham, MA 02451, USA
Int J Clin Pract 60:258-64. 2006..Our study confirms that, in routine medical practice, warfarin is not prescribed for substantial numbers of eligible patients, and anticoagulation control with warfarin is suboptimal for many of those at risk for thromboembolism...
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare dataKathleen Lang
Boston Health Economics Inc, Waltham, Mass, USA
Arch Otolaryngol Head Neck Surg 130:1269-75. 2004..CONCLUSION: These results suggest that the health economic burden of SCCHN is substantial, with costs that are comparable with or higher than those of other solid tumors...
Predictors of hospital length of stay and cost in patients with intracerebral hemorrhageM W Russell
Boston Health Economics, Waltham, MA 02451, USA
Neurology 67:1279-81. 2006..Mean LOS (cost) was 7.7 days (15,256 dollars) (survivors: 9.6 days, 17,442 dollars). Patient, hospital, and payer characteristics accounted for 69.1% of variation in cost per discharge...
The economic burden of intracerebral hemorrhage: evidence from managed careMason W Russell
Boston Health Economics, Waltham, Massachusetts 02451, USA
Manag Care Interface 19:24-8, 34. 2006..Treatment costs for ICH to private payers appear to be considerable and may reflect a sizable long-term financial burden to U.S. health plans...
Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) dataJeffrey D Miller
Boston Health Economics, Inc, 20 Fox Road, Waltham, Massachusetts 02451, USA
COPD 2:311-8. 2005..Results of our study indicate that COPD-associated healthcare utilization and expenditures are considerable, and that annual per-patient costs of COPD are comparable to those of other chronic diseases of the middle-aged and elderly...
Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literatureTalia S Foster
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
COPD 3:211-8. 2006..Cost-of-illness studies using recent data underscore the substantial current cost burden of COPD in the U.S...
Effect of the Heart At Work program on awareness of risk factors, self-efficacy, and health behaviorsCheryl Pegus
Pfizer, Inc, New York, N.Y, USA
J Occup Environ Med 44:228-36. 2002..They also were more likely to begin treatment for hypertension, to report fewer sick days, and to have plans to improve their diet and lose weight. These findings suggest that the Heart At Work program had a favorable overall impact...
Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare dataKathleen Lang
Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
Clin Gastroenterol Hepatol 7:198-204. 2009..This study provides detailed estimates of lifetime and phase-specific colorectal cancer (CRC) treatment costs...
Excess mortality, length of stay, and costs associated with serious hemorrhage among trauma patients: findings from the National Trauma Data BankLuke Boulanger
Boston Health Economics, Inc, Waltham, MA 02451, USA
Am Surg 73:1269-74. 2007..05). In both blunt and penetrating trauma cases, serious hemorrhage is significantly associated with excess mortality, longer hospital stays, and higher costs...
Quality-adjusted life years in cancer: pros, cons, and alternativesR M Woodward
Boston Health Economics, Inc, Waltham, MA 02451, USA
Eur J Cancer Care (Engl) 22:12-9. 2013..In this paper, we summarise the use of the quality-adjusted life years to assess the value of cancer care and suggest potential ways to improve upon value measurement in cancer coverage and reimbursement decisions...
Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemiaKathleen Lang
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Am J Health Syst Pharm 59:941-8. 2002..Gemtuzumab ozogamicin appeared to be associated with equivalent survival and fewer total days of hospitalization than conventional chemotherapy in adults with relapsed AML...
Migraine frequency and health utilities: findings from a multisite surveyJeffrey S Brown
Department of Ambulatory Care and Prevention, Harvard Medical School Harvard Pilgrim Health Care, Boston, MA, USA
Value Health 11:315-21. 2008..Assess the relationship between migraine frequency and health utility...
Cost effectiveness of topiramate in the prevention of migraines in the United States: an updateJeffrey S Brown
Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
Manag Care Interface 19:31-8. 2006..Model results were sensitive to baseline migraine-days, response probability, and probability of an attack being treated with a triptan. Topiramate may be a cost-effective treatment for the prevention of migraine...
Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatmentJeffrey S Brown
Boston Health Economics, Inc, Waltham, MA 02451, USA
Headache 45:1012-22. 2005..However, results from our model suggest that the use of TPM in prevention of migraine may offer reasonable value for money relative to many well-accepted medical interventions...
Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeriesBin Zhang
Boston Health Economics, Inc, 20 Fox Road, Waltham, MA 02451, USA
Curr Med Res Opin 25:943-50. 2009..Specifically, this study sought to test the hypothesis that the application of reversal agents in surgeries using a neuromuscular block would be associated with a decrease in elapsed OR time...
Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspectiveJeno P Marton
Pfizer Inc, New York, NY 10017, USA
Respir Med 100:996-1005. 2006..CONCLUSIONS: COPD places a substantial financial burden on State Medicaid programs. These findings may be of interest to clinicians and policy-makers involved in preventing or managing this chronic disease...
